指南与共识血栓与止血

肝素诱导血小板减少症血小板活化试验诊断标准化:ISTH-SSC免疫介导血小板疾病小组委员会意见

Standardization of Platelet Activation Tests for the Diagnosis of Heparin-Induced Thrombocytopenia: Communication from the ISTH-SSC Subcommittee on Immune-Mediated Platelet Disorders.
指南 / 共识 · J Thromb Haemost · 2026-05-27

肝素诱导血小板减少症(HIT)是肝素治疗的严重免疫不良反应,需免疫学检测联合血小板活化试验确诊。该共识针对血小板活化试验的分析前和分析变量提出标准化建议,涵盖血清素释放试验、肝素诱导血小板活化、血小板聚集、流式及多电极聚集法等,旨在提高诊断准确性并改善临床结局。

要点

  • HIT诊断需免疫学检测抗PF4/肝素抗体联合血小板活化试验确认致病性。
  • 免疫分析法敏感性高但特异性不足,无法区分致病与非致病抗体。
  • 标准化样本采集、供者选择、血小板制备及肝素浓度可提升试验准确性。

核心结论

  • 实施标准化方案和改善试验协调可提高HIT血小板活化试验的诊断准确性,最终改善疑似HIT患者的临床结局。

研究设计与样本

  • 该文件为ISTH-SSC免疫介导血小板疾病小组委员会的专家共识,讨论多种血小板活化试验的分析前和分析变量。

主要发现

  • HIT由靶向PF4/肝素复合物的血小板活化IgG抗体引起,导致FcγRIIA介导的多细胞活化和高凝状态。
  • 血小板活化试验对确诊至关重要,但标准化程度低且未广泛开展。
  • 共识讨论了血清素释放试验、肝素诱导血小板活化、血小板聚集试验、流式细胞术及肝素诱导多电极聚集法的方法学考虑。

关键数值与推荐

  • 强调样本采集、供者选择、血小板制备、肝素浓度及结果解读(包括对照策略和不确定结果处理)的关键性。
  • 概述了各试验的具体操作程序和性能特征,突出每种方法的优势和局限性。

临床怎么用

  • 实验室应实施标准化协议并改善试验协调,以优化血小板活化试验在HIT诊断中的应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heparin-induced thrombocytopenia (HIT) is a serious immune-mediated adverse effect of heparin therapy, characterized by thrombocytopenia and a paradoxical increase in thrombotic risk. HIT results from platelet-activating immunoglobulin G antibodies targeting complexes of platelet factor (PF)4 and heparin, leading to FcγRIIA-mediated multicellular activation and a hypercoagulable state. Accurate diagnosis requires both immunological detection of antiplatelet factor 4/heparin antibodies and platelet activation confirmation of their potential pathogenicity. Immunoassays, while highly sensitive, lack clinical specificity due to their inability to distinguish between pathogenic and nonpathogenic antibodies. Platelet activation assays, although essential for definitive diagnosis, remain poorly standardized and are not widely available. This study addresses critical preanalytical and analytical variables influencing the accuracy of platelet activation HIT testing. It discusses key methodological considerations across various platelet activation assays, including the serotonin release assay, heparin-induced platelet activation, platelet aggregation tests, flow cytometry-based assays, and the heparin-induced multielectrode aggregometry method. Emphasis is placed on sample collection, donor selection, platelet preparation, heparin concentrations, and interpretation of results, including control strategies and troubleshooting indeterminate outcomes. The document also outlines assay-specific procedures and performance characteristics, highlighting the strengths and limitations of each method. By implementing standardized protocols and improving assay harmonization, diagnostic accuracy can be enhanced, ultimately improving clinical outcomes for suspected patients with HIT. This work reflects a collaborative expert consensus and aims to support laboratories in optimizing the application of platelet activation assays in HIT diagnostics.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Althaus K, Bakchoul T, Gruel Y, et al. Standardization of Platelet Activation Tests for the Diagnosis of Heparin-Induced Thrombocytopenia: Communication from the ISTH-SSC Subcommittee on Immune-Mediated Platelet Disorders. J Thromb Haemost. 2026. PMID: 42208940. doi:10.1016/j.jtha.2026.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。